폴라리스AI파마

041910KOSDAQ

64.8 / 100

Reference Date: 2026-09-08

Financial Score26.5 / 40

News Sentiment21.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Polaris AI Pharma primarily operates in API (Active Pharmaceutical Ingredient) and CDMO (Contract Development and Manufacturing Organization) sectors, with API contributing 96.3% of its 2025 revenue. The company focuses on expanding high-value CDMO services while maintaining strong collaborations with domestic and international pharmaceutical firms, particularly emphasizing exports to the demanding Japanese market.

Number of Employees

167people

Average Salary

51.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.72Industry Average 15.005.0Point

In line with industry avg

PBR

0.53Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

4.66Industry Average 8.002.5Point

Below industry avg

Debt Ratio

22.92Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼7.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲807.7% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
폴라리스AI핸디, 사명 변경 후 첫 사내 해커톤 성료
사명 변경 후 첫 사내 해커톤 성공으로 혁신적 아이디어 발굴 및 구현, 기업 성장 동력 강화.
Positive
폴라리스AI파마, '국내 제조' 루라시돈 원료의약품 DMF 등록
폴라리스AI파마의 루라시돈 원료의약품 DMF 등록 성공으로 국내 제조 역량 강화 및 시장 경쟁력 향상 기대.
Positive
폴라리스오피스, 별도 영업익 112%↑…AI·AX 투자 성과
폴라리스오피스의 AI 및 AX 투자로 인해 B2B 매출 성장과 신규 서비스 성공으로 영업이익이 크게 증가했다.

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 5,440Won52-week high 8,92052-week low 4,300

1-month return3.0Point

1m -0.37% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14